ALVEOLAR RHABDOMYOSARCOMA
Clinical trials for ALVEOLAR RHABDOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new ALVEOLAR RHABDOMYOSARCOMA trials appear
Sign up with your email to follow new studies for ALVEOLAR RHABDOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a targeted drug boost chemo for a rare childhood cancer?
Disease control OngoingThis study tests whether adding the drug temsirolimus to standard chemotherapy helps children and young adults with intermediate-risk rhabdomyosarcoma, a rare muscle cancer. About 325 participants receive either chemo alone or chemo plus temsirolimus. The goal is to see if the co…
Matched conditions: ALVEOLAR RHABDOMYOSARCOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 12:08 UTC
-
New drug combo aims to beat tough childhood cancer
Disease control OngoingThis study tests whether adding a drug called vinorelbine to standard chemotherapy can help children and young adults with high-risk rhabdomyosarcoma, a rare muscle cancer. About 118 participants will receive either the standard treatment or the new combination, followed by maint…
Matched conditions: ALVEOLAR RHABDOMYOSARCOMA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
Gene hunt in kids with rare cancer aims to unlock prognosis secrets
Knowledge-focused OngoingThis study collects saliva or cheek cell samples from 900 children with a rare muscle cancer called rhabdomyosarcoma, along with samples from their parents. Researchers look for genetic mutations that may be linked to the disease. The goal is to learn more about how these gene ch…
Matched conditions: ALVEOLAR RHABDOMYOSARCOMA
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated May 26, 2026 11:09 UTC